Latest Publications
Ritonavir research selected as a top “Remarkable Accomplishment”
Improved Pharma is pleased to announce that their ritonavir research with Varda Space Industries that was published earlier this year has been selected by Organic Process Research & Development as one of the top “remarkable accomplishments from the scientific literature that areRead more
Structure of Amorphous Materials
Pharmaceutical materials can exist in a crystalline or amorphous state. Figure 1 illustrates the crystalline state as a perfectly ordered solid with molecules (circles) packed in an orderly array. Figure 1 also illustrates anRead more
Improved Pharma announces registration now open for Spring Pharmaceutical Synchrotron XRPD Workshop
WEST LAFAYETTE, IND. (PRWEB) APRIL 04, 2023 Improved Pharma is pleased to announce the return of this popular and informative workshop. Registration and additional information can be found here: SPS-XRPD Workshop Over 20 guest lecturers have been gathered toRead more
Improved Pharma presenting and sponsoring at ACS Spring 2023 national meeting
WEST LAFAYETTE, IND. (PRWEB) MARCH 21, 2023 Improved Pharma will be at the ACS Spring 2023 National Meeting to be held in Indianapolis March 26 – 30, 2023. There are two opportunities to interact with Improved Pharma atRead more
Late Appearing Polymorphs: Ritonavir
Since the ritonavir crisis in 1998, when a lifesaving HIV protease inhibitor had to be withdrawn from the market for almost a year due to a sudden and unpredictable appearance of a new less solubleRead more
Late Appearing Polymorphs: Atorvastatin
In the early 1990’s SSCI, Inc. began working with Parke-Davis Warner-Lambert by providing X-ray diffraction measurements on samples manufactured at its Holland, Michigan manufacturing facility. One of the compounds under investigation was atorvastatin calcium. AtorvastatinRead more